Skip to main content

Week 7 - MBA 6101 - Artificial Intelligence and Machine Learning Impacts on the Pharmaceutical Industry

Health IT Analytics posted the article ChatGPT Passes US Medical Licensing Exam (USMLE) Without Clinician Input in February of this year. With this news, questions arose in my mind about how Artificial Intelligence (AI) and Machine Learning (ML) may impact the job market of the pharmaceutical industry. While the artificial intelligence tool scored only 60% accuracy on the exam, it does beg the question will clinicians soon no longer be required for safety data review and analysis in clinical trials or pharmacovigilance?



In my own experience, medical decisions surrounding pharmaceuticals requires the ability to critically think about the reported data and understand the medical impact that may be had. This can be made difficult by poor data entry by the primary investigator delivering medical care the the subjects on the clinical trial. It can also require extensive knowledge of the pharmacokinetics of the drug under study. For this reason, I do not think we all need to start looking for new jobs. However, I do think it is imperative that we think about the strategic implications of these technology tools on data analytics.




In Surfing the Tsunami: An Introduction to Artificial Intelligence and Options for Responding, Todd Kelsey describes the three approaches one can take with AI as adapting, adopting, or becoming adept with AI. The option to adapt being the minimal approach of understanding there will be impact of AI and being aware of what that impact could be. Adopting AI is the next tier, where a person or company may decide to implement some available technologies to their practices. This is better than just being aware of the current technology options out there, but still leaves gaps as you are expecting existing technology to fit with your processes. The idea of becoming adept with AI means that you take on a role, either formally or informally, of the data scientist to develop different technology tools in your business area to leverage AI and ML to improve your processes.



For me, becoming adept is not just optimal but necessary. Understanding that AI and ML is moving faster and faster every day, it is imperative that we understand what these technologies are capable of and to start leveraging them now. Otherwise, the pharmaceutical industry will move on without its data reviewers and analysts, potentially to the detriment of the patient or company. This is why it is important to understand the limitations of AI and ML. Since ChatGPT barely passed the USMLE on it's own, this means that clinicians are still providing valuable insight that AI and ML are not yet capable of. Using intellectual curiosity and critical thinking, we should leverage data sciences programming where we can but remember that clinicians should be involved in developing that programming to provide their unique insight.

Comments

Popular posts from this blog

Week 2 - MBA 6101 - Creating a Website and Domain with Google Sites: As Easy as 123

As a beginner in website design, I would have thought it necessary to have some coding or design background to create my own website. Of course, I remember the days of Myspace where we all had our own "websites," using the most basic of HTLM codes to customize wallpaper or music. But Google Sites makes it even easier than those days of the past, with templates, simple blocking, options to upload images directly using a Google Image search, and even embedding links, all with a simple click of a button or two. You should know, a Google account is required to create a site using Google Sites. If you need assistance with setting up a Google account you can find information on that here . Once you have an account set up you will need to access your Google Drive . From here, you can create a multitude of documents, forms, or even a site. To create a website, simply click the "New" button, hover over "More," and click on "Google Sites."         From her

Week 4 - MBA 6101 - A Marketing Plan: The Cornerstone of Your Success

According to Guerilla Marketing  by Jay Conrad Levinson, a good marketing plan can be the difference between success and failure for a business. He suggests that an entrepreneur put together their market plan before ever selling their first product or providing service for the first time. A marketing plan should be simple and straightforward, it will help define the identity of a business and how the company will interact with customers. The first step is to answer the below seven questions to develop a marketing plan to guide your business strategy. What is the purpose of marketing your product or service? Why should customers choose your product or services? Who is your target audience? What marketing tools will you use to meet your purpose? Where do you fit in within the market? How do you want customers to see or identify your company? How much are you willing to invest in your marketing plan? For instance, if you were looking to start consulting for a pharmaceutical company the be

Week 2 - MBA 6101 - Artificial Intelligence and Machine Learning Application in Safety Oversight for Clinical Trials

Clinical trials are crucial for the development and approval of new medical treatments and drugs. However, ensuring the safety of the participants is of utmost importance. This is where the use of Artificial Intelligence (AI) and Machine Learning (ML) can play a significant role. These technologies can help streamline the safety oversight process and make it more effective, thereby improving the overall quality of clinical trials. Here are some of the key applications of AI and ML in safety oversight for clinical trials: 1.    Adverse Event Monitoring: AI algorithms can be trained to detect and identify adverse events that occur during a clinical trial. The algorithms can analyze large amounts of data quickly and accurately, which can help identify potential safety risks earlier and prevent adverse events from reoccurring. 2.   Predictive Modeling: AI algorithms can be used to develop predictive models that can help identify participants who are at higher risk of experiencing adverse e